Adam Crystal, M.D., Ph.D., is a distinguished leader in the field of oncology and serves as the President of Research and Development at TANGO THERAPEUTICS INC. Dr. Crystal brings a wealth of experience and expertise to his role, having earned both his medical degree and doctorate from Harvard Medical School and the Massachusetts Institute of Technology, respectively. His dual training in medicine and biomedical sciences has equipped him with a unique perspective on cancer research and drug development. Throughout his career, Dr. Crystal has made significant contributions to the understanding and treatment of cancer. Prior to joining TANGO THERAPEUTICS, he held positions at renowned institutions such as the Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard. His research has focused on identifying novel therapeutic targets and developing innovative treatment strategies for various cancer types. Dr. Crystal's work has been published in numerous high-impact scientific journals, and he has received several prestigious awards for his contributions to the field of oncology. As President of Research and Development at TANGO THERAPEUTICS INC, Dr. Crystal plays a pivotal role in advancing the company's mission to develop transformative cancer therapies. He oversees a team of dedicated scientists and researchers working on cutting-edge projects aimed at targeting cancer vulnerabilities. Under his leadership, TANGO THERAPEUTICS is making significant strides in the development of novel cancer treatments, leveraging Dr. Crystal's expertise in translational research and drug development to bring new hope to patients battling cancer.